Tamaka Shwasa is one among the five types of Shwasa Roga explained in Ayurveda classic. Tamaka Shwasa shows close similarity with bronchial asthma. Asthma is disease of the human respiratory system in which the airways constrict and become narrow, often in response to a "trigger" such as exposure to an allergen, cold air, exercise or emotional stress. Due to rapid industrialization and urbanization, asthma prevalence is predicted to increase more rapidly in the coming years. Despite the availability of a wide range of drugs for the treatment of asthma, the relief offered by them is mainly symptomatic and short lived. Moreover the side effects of these drugs are also quite disturbing. Medicinal plants have been known for millennia and are highly esteemed all over the world as a rich source of therapeutic agents for the prevention of diseases and ailments. The importance of herbal medicine in the treatment of asthma is indisputable. In Ayurveda Pushkarmool is mainly used as a bronchodilator and expectorant. Pushkarmool has antihistaminic and a bronchodilator action that make it work in Shvasa roga which make it very effective in the management of bronchial asthma.
INTRODUCTION
The three main constituents of living body are considered as vata, pitta, kapha which are collectively referred to as doshas and according to Ayurveda imbalance to their existing proportion is responsible for generation of any disease. In asthma, dosha imbalance is caused by simultaneous aggravation of prana vayu due to obstruction of kapha and vata (Sharma and Dash, 2004) . Several drugs have been described in Ayurveda samhita as single or compound drugs for Shvasa. In Ayurveda asthma is closely resembles with Tamak Shvasa. Tamak Shvasa is mentioned as one of the varieties among five type of Shvasa. Tamak Shvasa is "swatantra vyadhi" having its own etiology, pathology and management. It is mentioned as "Yapya vyadhi" (Tripathi, 2011) The word 'asthma' is derived from the Greek meaning 'panting' or 'laboured breathing'. Asthma is a condition characterized by a paroxysmal wheezing dyspnea (difficulty in breathing), mainly expiratory (Nagarajan and Naik, 1995) . Asthma is the disease of the respiratory system in which the airways constrict, become inflamed, and are lined with excessive amounts of mucus, often in response to one or more "triggers, " such as exposure to an increased industrialization, environmental stimulate (or allergen), cold air, exercise, or emotional stress (Homer, 2007) .
Asthma is one of the most common chronic diseases in the world. It is estimated that around 300 million people in the world currently have asthma. In the global burden of asthma report of the Global Initiative for Asthma, the prevalence of asthma in different countries has been considered to range from 1% to 18% of the population. The prevalence of asthma increases as a community adopt modern life styles and become urbanised. With the proportion of the world's population living in urban areas projected to increase from 45 % to 59 % in 2015, there is likely to be a marked increase in the number of people with asthma worldwide over the next two decades. It is estimated that there may be as additional 100 million people with asthma by 2025 (Masoli M. et al, 2004) . Hundreds of herbal drugs are being screened at present for better therapeutics principle throughout the world. Herbal preparations have been cited as the third most popular complementary treatment modality. The therapeutic efficacy of herbal combination in asthma is due to multiple blocking and homeostasis of very complex and interdependent cellular and mediator networks supporting and involved in the inflammatory process of asthma whereas modern drugs are aimed at blocking one mediator alone would be unlikely to have any significant effect on disease process (Gabrielian, et. al., 2004) . Almost all the traditional health care delivery systems claim effective management of asthma. Ayurveda has a strong scientific background, which was translated into recommendations for clinical management of this condition. (Tavhare and Nishteswar, 2014) . In this study single herbal drug Pushkarmool are taken for review in the management of asthma.
HERBAL DRUG PUSHKARMOOL (Inula racemosa)
Pushkarmool is an herbaceous perennial plant which belongs to family Asteraceae. According to Aacharya Charaka it is shvasahara and Hikkanigrahana dravya. The root of Inula racemosa is an effective traditional herbal medicine for bronchial asthma. In Charak Samhita, sutrasthana, ch-25 Acharya Charka considered the use of pushkarmool in the shvasa (Tripathi, 2004) .
Bhavprakasha Nighantu, Dhanvantri Nighantu and Raj Nighantu explain the properties of Pushkarmool in the management of Shvasa. Pushkarmool is a respiratory supports that smoothens the irritated bronchial tree. It is rejuvenative for lungs. It is useful in many conditions including inflammation, anorexia, cough, hiccough, cardiac and bronchial asthma, bronchitis, anaemia and general debility. According to Charaka it is the drug of choice in Hikka, Shvasa and Parshwashool. Pushkarmool has antihistaminic and a bronchodilator action that make it work in Shvasa roga. The root of pushkarmool is useful in all edematous condition and helpful in curing swelling and pain. The root of this drug is bitter, acrid, thermogenic, aromatic, stimulant, expectorant,bronchodilator (Pharmacologyonline.silae.it/files/archieve s/2009/vol-2/008).
The chemical constituents of root are inulin (10%), aromatic oil (1.3 %). Main alkaloid in oil is Alantolactone. Roots of Inula racemosa gave β-sitosterol, dancosterol, and isoalantolactone (Girish, 2006) . In Ayurveda it is mainly used as bronchodilator and expectorant. Pushkarmool has ushna virya and vatakaphahara properties which is the main dosha in bronchial asthma. It can produce relaxation of bronchioles like adrenaline but action is less powerful and took a longer time to develop and also persisted for a longer period. In bronchial asthma the srotodushti is of sanga which is relieved by ushna and shvasahara property of drug. By these properties they break the pathogenesis of Tamak Shvasa and help in curing. Pushkarmool is mainly used in the form of Churna (Lokhande and Gawai, 2007) . Bronchial asthma is a reversible obstructive airway disease along with bronchial hyper responsiveness as prominent features. The main pathology includes airway obstruction, bronchial hyper responsiveness and chronic inflammation. The main doshas included are vata and kapha. The root of Pushkarmool is described in various Ayurvedic classics for the management of asthma. It is mainly used as bronchodilator and expectorant. Due to kaphavatahara properties it helps in balancing the disturbed doshas i.e. vata and kapha in bronchial asthma. It can produce relaxation of bronchioles like adrenaline but action is less powerful and took longer time. Sanga type of srotodushti in Tamak Shvasa is relived by ushna and shvasahar properties of Pushkarmool. Pushkarmool has katu and tikta rasa which act on kapha dosha and help in restoring the function of amashaya which is the adhishthana of bronchial asthma. By these properties it helps in breaking the pathogenesis of asthma and help in management of asthma. Pushkarmool is already mentioned as shvasahara dravya in Raj Nighantu, Dhanvantri Nighantu, Charaka Samhita which is . The alcoholic extract of the root of Inula racemosa is also protected against bronchi spasms induced by histamines, pollen, etc. The anti-asthmatic activity of the roots extracts of I. racemosa was evaluated by measuring the antagonistic effect on histamine induced contraction, milk induced eosinophilia, leukocytosis and protection against mast cell degranulation in wistar rats. Petroleum ether extract the plant at a dose of 4 mgmL−1 (55.41 ± 3.04) and 10 mgmL−1 (48.87 ± 1.36) exert significant antagonistic effect on histamine induced (1.6 μgmL−1) contraction as compared to its ethanol and aqueous extract. Milk-induced eosinophilia in mice of petroleum ether extract at a dose of 50 & 100 mgkg−1. Intraperitoneal (i.p.) was found to be 44.77% and 54.36% respectively as compared control group (43.1 ± 2.41). Similarily, dose dependent inhibition of petroleum ether extract at a dose of 50 and 100 mgkg−1, i.p. on milk induced leukocytosis (59.53% and 77.47%) supports the adaptogenic potential of the drug. Pre-treatment with petroleum ether extract at a dose of 100 mgkg−1, i.p. significantly offered protection (74.68%) against mast cell degranulation when compared with control group (Singh et.al., 1980 ) Gautam et. al., 2009 also investigated the anti-asthmatic activity of Inula racemosa Hook. F. by using petroleum ether (60-80o), ethanol (95%), water extract of air dried roots of the plant obtained by successive extraction. Petroleum ether extract (PEEIR) at a dose of 4 mg/ml (55.41±3.04) and 10 mg/ml (48.87±1.36) exert significant antagonistic effect (p<0.05) on histamine induced (1.6μg/ml) contraction as compared to its ethanol and water extract. A dose dependent contraction was observed in goat tracheal chain preparation. 
Conclusion:
Plants are always an exemplary source of drugs; in fact many of the currently available drugs were derived either directly or indirectly from them. In the past decade, research has been focused on scientific evaluation of traditional drugs of plant origin for the treatment of various diseases. There are an increasing number of herbs that can be used to treat many of the precursor or chronic conditions of bronchial asthma. Many synthetic drugs are used to treat asthma, but they are not completely safe for long term use. Bronchial asthma is a reversible obstructive airway disease along with bronchial hyper responsiveness as prominent features. The main pathology includes airway obstruction, bronchial hyper responsiveness and chronic inflammation. The root of Pushkarmool is described in various Ayurvedic classics for the management of asthma. It is mainly used as bronchodilator and expectorant. It can produce relaxation of bronchioles like adrenaline but action is less powerful and took longer time. Sanga type of srotodushti in Tamak Shvasa is relived by ushna and shvasahar properties of Pushkarmool. Pushkarmool has katu and tikta rasa which act on kapha dosha and help in restoring the function of amashaya which is the adhishthana of bronchial asthma. By these properties it helps in breaking the pathogenesis of asthma and help in management of asthma. Pushkarmool is already mentioned as shvasahara dravya in Raj Nighantu, Dhanvantri Nighantu, Charaka Samhita which is now again proved by latest researches. Latest research explains the mast cell stabilizing activities, antibacterial and anti-asthmatic effect of root of Inula racemosa. So as a single herb Pushkarmool is very effective in the management of bronchial asthma. 
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